Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
clinical trials
life sciences
national blog main
san francisco
4
×
san francisco blog main
san francisco top stories
boston blog main
boston top stories
ipo
national top stories
cancer
cancer drugs
deals
investing
new york blog main
new york top stories
renaissance capital
revolution medicines
sanofi
the column group
third rock ventures
warp drive bio
10x genomics
amgen
antibiotics
arvinas
astrazeneca
biotech ipos
boston
boulder/denver
boulder/denver blog main
boulder/denver top stories
carbapenem-resistant enterobacteriaceae
celgene
cobimetinib
colorectal cancer
desmoid tumors
detroit
detroit blog main
What
ipo
4
×
way
cancer
life
medicines
proteins
research
revolution
science
week
biotech
biotechs
boost
cancer’s
chose
close
companies
company
despite
device
disease
drug
family
firms
followed
frontiers
genomics
hardest
haul
hit
hottest
hunters
ipos
known
led
make
maps
markets
medical
open
Language
unset
Current search:
ipo
×
" san francisco "
×
@xconomy.com
4 years ago
Revolution Medicines IPO Reels In $238M to Take On RAS in Cancer
@xconomy.com
4 years ago
Revolution Medicines Maps Out an IPO to Reach Cancer’s Frontiers
@xconomy.com
4 years ago
SpringWorks and Satsuma Boost This Week’s Biotech IPO Haul to $595M
@xconomy.com
5 years ago
Six Life Science Firms Close Q3 with an IPO, More Are on the Way